Rocket Pharmaceuticals, Inc.

RCKT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001281895

SEC filings (opens in a new tab)

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of RCKT: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	178	1	192	+15
Shares	91.2M	6.19M	92.7M	+7.66M (+9.0%)
Value	$1.96B	$133.3M	$1.71B	−$121.4M (−6.6%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to RCKT in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	6,370,721	$117.7M	0.00%
MPM Oncology Impact Management LP	1,066,373	$19.7M	2.95%
Great Lakes Advisors, LLC	347,625	$6.42M	0.05%
Prosight Management, LP	159,369	$2.94M	0.75%
Walleye Capital LLC	138,403	$2.56M	0.03%
ExodusPoint Capital Management, LP	65,618	$1.21M	0.01%
Hudson Bay Capital Management LP	65,000	$1.20M	0.01%
Squarepoint Ops LLC	53,039	$979.6K	0.00%
Point72 Asset Management, L.P.	48,096	$888.3K	0.00%
B. Metzler seel. Sohn & Co. Holding AG	34,418	$635.7K	0.01%
Main Management ETF Advisors, LLC	32,592	$602.0K	0.03%
Intech Investment Management LLC	28,555	$527.4K	0.01%
HRT Financial LP	26,149	$482.0K	0.00%
AQR Capital Management LLC	18,908	$349.2K	0.00%
SEI Investments Co	17,060	$315.0K	0.00%
Tudor Investment Corp Et Al	16,787	$310.1K	0.00%
Mirador Capital Partners LP	16,774	$309.8K	0.06%
Brevan Howard Capital Management LP	16,720	$308.8K	0.01%
Verition Fund Management LLC	15,681	$289.6K	0.00%
XTX Topco Ltd	15,503	$286.3K	0.02%
Jefferies Financial Group Inc.	14,500	$267.8K	0.00%
Kennedy Capital Management, Inc.	11,843	$218.7K	0.00%
SG Americas Securities, LLC	6,128	$113.0K	0.00%
Values First Advisors, Inc.	5,840	$107.9K	0.06%
Acadian Asset Management LLC	3,553	$65.0K	0.00%
Leonteq Securities AG	2,500	$46.2K	0.01%
Spire Wealth Management	2,001	$37.0K	0.00%
Aster Capital Management (DIFC) Ltd	1,137	$21.0K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	304	$5.62K	0.00%
Point72 (DIFC) Ltd	197	$3.63K	0.00%
Capital Analysts, LLC	175	$3.00K	0.00%
Sterling Capital Management LLC	68	$1.26K	0.00%
Parallel Advisors, LLC	59	$1.09K	0.00%
Allworth Financial LP	11	$204	0.00%

Sold out (19)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of RCKT in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
EcoR1 Capital, LLC	508,393	$10.9M
Adage Capital Partners GP, L.L.C.	200,000	$4.31M
GMT Capital Corp	188,100	$4.05M
Neuberger Berman Group LLC	150,578	$3.24M
Prudential Financial Inc	102,705	$2.21M
Renaissance Technologies LLC	99,574	$2.14M
Strategic Financial Concepts, LLC	21,981	$895.0K
Assenagon Asset Management S.A.	29,986	$645.6K
Principal Financial Group Inc	24,702	$531.8K
Los Angeles Capital Management LLC	24,518	$527.9K
Pitcairn Co	10,089	$217.2K
Group One Trading, L.P.	6,331	$136.3K
Aquatic Capital Management LLC	3,200	$68.9K
STRS Ohio	2,600	$56.0K
Catalyst Funds Management Pty Ltd	2,100	$45.2K
Pacer Advisors, Inc.	669	$14.4K
Meeder Asset Management Inc	178	$3.83K
Innealta Capital, LLC	49	$1.05K
Evermay Wealth Management LLC	25	$539

Not filed for Q3 2024 yet (1)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	6,192,627	$133.3M